OA08911A - Diagnosis and treatment of double-stranded RNA deficiency states. - Google Patents

Diagnosis and treatment of double-stranded RNA deficiency states.

Info

Publication number
OA08911A
OA08911A OA59419A OA59419A OA08911A OA 08911 A OA08911 A OA 08911A OA 59419 A OA59419 A OA 59419A OA 59419 A OA59419 A OA 59419A OA 08911 A OA08911 A OA 08911A
Authority
OA
OAPI
Prior art keywords
diagnosis
double
treatment
stranded rna
deficiency states
Prior art date
Application number
OA59419A
Other languages
English (en)
Inventor
William A Carter
Original Assignee
Hem Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Res Inc filed Critical Hem Res Inc
Publication of OA08911A publication Critical patent/OA08911A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
OA59419A 1987-09-04 1988-09-05 Diagnosis and treatment of double-stranded RNA deficiency states. OA08911A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9352387A 1987-09-04 1987-09-04

Publications (1)

Publication Number Publication Date
OA08911A true OA08911A (en) 1989-10-31

Family

ID=22239406

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59419A OA08911A (en) 1987-09-04 1988-09-05 Diagnosis and treatment of double-stranded RNA deficiency states.

Country Status (15)

Country Link
JP (1) JPH0825884B2 (zh)
KR (1) KR890005277A (zh)
CN (1) CN1031651A (zh)
AU (3) AU2186488A (zh)
CA (1) CA1336683C (zh)
DK (1) DK491088A (zh)
FI (1) FI884069A (zh)
IL (1) IL87664A (zh)
NO (1) NO883868L (zh)
NZ (1) NZ226033A (zh)
OA (1) OA08911A (zh)
PH (1) PH26320A (zh)
PT (1) PT88415B (zh)
RU (1) RU2001917C1 (zh)
ZA (1) ZA886581B (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1088344C (zh) * 1997-10-17 2002-07-31 青岛市卫生防疫站 富硒或富锌蚯蚓干粉或提取物的制造方法
US20060035859A1 (en) * 2003-05-16 2006-02-16 Hemispherx Biopharma Treating severe and acute viral infections

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024222A (en) * 1973-10-30 1977-05-17 The Johns Hopkins University Nucleic acid complexes
JPS57200310A (en) * 1981-05-26 1982-12-08 Merck & Co Inc Local application of interferon inducer
AU1820388A (en) * 1987-07-17 1989-01-19 Hem Research, Inc. Double stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles

Also Published As

Publication number Publication date
KR890005277A (ko) 1989-05-13
PT88415B (pt) 1992-10-30
JPH0825884B2 (ja) 1996-03-13
CA1336683C (en) 1995-08-15
DK491088D0 (da) 1988-09-02
IL87664A (en) 1995-03-15
FI884069A (fi) 1989-03-05
DK491088A (da) 1989-03-05
RU2001917C1 (ru) 1993-10-30
AU1001495A (en) 1995-03-30
AU1736692A (en) 1992-07-30
IL87664A0 (en) 1989-02-28
JPH01131118A (ja) 1989-05-24
FI884069A0 (fi) 1988-09-02
NO883868L (no) 1989-03-06
NO883868D0 (no) 1988-08-30
PH26320A (en) 1992-04-29
NZ226033A (en) 1999-08-30
PT88415A (pt) 1989-07-31
ZA886581B (en) 1989-04-26
AU2186488A (en) 1989-03-09
CN1031651A (zh) 1989-03-15

Similar Documents

Publication Publication Date Title
EP0205579A4 (en) METHODS AND COMPOSITIONS FOR USE IN THE DIAGNOSIS AND TREATMENT OF AUTOIMMUNE DISEASES.
GB8708115D0 (en) Coagulation treatment of fluids
EP0252940A4 (en) ANTI-DETECTION RNA FOR THE TREATMENT OF RETROVIRAL DISEASES.
AU1595088A (en) Kernel oils and disease treatment
AU1279788A (en) Compounds and treatment
GB8711363D0 (en) Ground-water treatment
GB8718422D0 (en) Chemical treatment
OA08911A (en) Diagnosis and treatment of double-stranded RNA deficiency states.
IL95751A0 (en) Dna sequences of the wunl gene and their use
ZA883975B (en) Treatment and diagnosis of footrot using the basic protease of b.nodosus
IE882676L (en) Diagnosis and treatment of double-stranded rna deficiency states
EP0411900A3 (en) Treatment of conditions involving excessive eating
GB8728162D0 (en) Threshold treatment
AU8094887A (en) Water treatment compositions and processes
AU4849997A (en) Diagnosis and treatment of double stranded deficiency states
AU2395288A (en) Metoprolol in the treatment and prophylaxis of heart disease
EP0411901A3 (en) Treatment of conditions involving excessive eating
PL267042A2 (en) Biological sewage treatment method
IE881524L (en) Preparation of double-stranded dna
PH25733A (en) 5-aryl-3h-1,2,4-triazol-3-ones, their use in the treatment of neurogenerative disorders
PL267073A1 (en) Mechanical and biological sewage treatment station
ZA889072B (en) Surgical swab and its production
EP0269024A3 (en) Use of 3-methyl-4-oxothiazolidin-2-ylidene-acetamide derivatives in the treatment of aids
GB8502680D0 (en) Biological treatment
GB8719190D0 (en) Treatment